Cardiogenic shock is an acute and serious medical condition characterized by a sudden and profound decline in the heart's ability to effectively pump blood, resulting in inadequate oxygen delivery to vital organs. This critical state often stems from various cardiac issues, including extensive heart attacks, severe heart failure, or other events compromising cardiac function. As the heart's pumping efficiency diminishes, blood pressure plummets, and essential organs, such as the brain and kidneys, face insufficient oxygenation. Recognizable symptoms may include rapid breathing, cold and clammy skin, confusion, and a weak pulse. Swift medical intervention is imperative to address the root cause and restore proper blood circulation. Treatment strategies may encompass medications to bolster heart function, deployment of mechanical support devices, or, in more severe instances, emergency procedures like angioplasty or coronary artery bypass surgery. Early detection and intervention remain pivotal to enhancing survival rates and reducing long-term complications associated with cardiogenic shock.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation